Tag: Phapros

Revisiting Phapros, Indofarma

Pharmaceutical firm Phapros, subsidiary of state-owned trading firm Rajawali Nusantara (RNI), performed better compared to state-owned Indofarma (INAF). In the first half (H1) of 2018, Phapros reported a 45,8% jump in net profit to Rp53 billion, while INAF only booked a net profit of Rp253 million, but significantly improved from loss Rp53.54 billion in H1 of last year.

Read More

Merger & Acquisition Updates

PT Rehabilitasi Lingkungan Indonesia, a company owned 100% by coal giant Adaro Energy (ADRO), has notified the Business Competition Supervisory Commission (KPPU) regarding its plan to acquire a company controlled by Kalla Group. Phapros, pharmaceutical subsidiary of state-owned trading firm Rajawali Nusantara (RNI), meanwhile, has acquired PT Lucas Djaja Group.

Read More
Loading
error: Content is protected !!